> Must have breakthrough product addressing a cardiovascular large unmet market.
> Must be willing to enter Dutch auction to sell off innovation within 3 years.
> Preferrably one 510K product that generates revenues in short run and a PMA blockbuster that creates higher profits long run.
> Must engage well with our scientific advisory board and cardiovascular mentorship team.
> Preferrably something likely to sell in 3 years to Medtronic, St. Jude, Boston Scientific, Abbott Labs, Cordis J&J or Sorin Biomedica.
> Preferrably a stem cell component to the technology.
Note – Cal-X Stars will only accept a maximum of 30 startups. 15 cardiovascular life science and 15 social good impact innovations maximum by charter. We are completely full now as of August 2014 for the next 5 years UNLESS we sell off, license out or drop a currrent portofolio company. Cal-Xelerator will accept up to 4 companies twice a year to enter the 108 day “create to great” startup launch program.